Mesenchymal Stem/Stromal Cells: CONSIDERATION OF COMPARTMENT EFFECT ON BIOMARKER ANALYSIS: LESSONS LEARNED FROM BRAINSTORM’S PHASE III CLINICAL TRIAL EVALUATING MSC-NTF CELL THERAPY IN ALS
Year: 2023
Type: article
Source: Cytotherapy
Authors: N. Blondheim-Shraga, H. Kaspi, Y.S. Levy, Y. Gothelf, N. Goyal, J. Berry, N. Staff, R. Kern, B. Boulanger, R. Aricha, J. Li, N. Abramov, J. Katz, R. Miller, A. Windebank, R. Bowser, M. Cudkowicz, R. Brown, S. Lindborg
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4376112539